Yuzo Fujino1,2, Morio Ueyama1,3,4, Taro Ishiguro4,5, Daisaku Ozawa1,3, Hayato Ito6, Asako Murata7, Eiichi Tokuda8, Yoshiaki Furukawa8, Toshiki Mizuno2, Hideki Mochizuki9, Hidehiro Mizusawa5, Keiji Wada4, Kinya Ishikawa5, Osamu Onodera10, Kazuhiko Nakatani7, Hideki Taguchi6, Yoshitaka Nagai1,3,4,9 (1.Department of Neurology, Kindai University Faculty of Medicine, Japan, 2.Department of Neurology, Kyoto Prefectural University of Medicine, Japan, 3.Department of Neurotherapeutics, Osaka University Graduate School of Medicine, Japan, 4.Department of Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Japan, 5.Department of Neurology and Neurological Science, Tokyo Medical and Dental University, Japan, 6.School of Life Science and Technology, Tokyo Institute of Technology, Japan, 7.Department of Regulatory Bioorganic Chemistry, The Institute of Scientific and Industrial Research, Osaka University, Japan, 8.Department of Chemistry, Keio University, Japan, 9.Department of Neurology, Osaka University Graduate School of Medicine, Japan, 10.Department of Neurology, Clinical Neuroscience Branch, Brain Research Institute, Niigata University, Japan)
Session information
Oral Presentation Award Nominee Session (Basic Research)
[AO-01] Oral Presentation Award Nominee Session (Basic Research)
Wed. May 31, 2023 3:35 PM - 5:05 PM Room1 (幕張メッセ国際会議場 2F コンベンションホール)
Chair:Dawson Ted M. (Johns Hopkins University School of Medicine, USA)
Daiki Takewaki1, Hiroaki Masuoka2, Yuya Kiguchi2, Wakiro Sato1, Wataru Suda2, Takashi Yamamura1 (1.National Center of Neurology and Psychiatry, Department of Immunology, Japan, 2.RIKEN, Laboratory for Microbiome Sciences, Japan)
Masaya Harada1,2, Katsuhisa Masaki1, Dai Matsuse1, Hiroo Yamaguchi1,3, Yuji Nishimura1, Ezgi Ozdemir1, Eizo Tanaka1, Tatsunori Tanaka4, Ryo Yamasaki1, Hideyuki Takeuchi5, Takayuki Taniwaki2, Noriko Isobe1, Jun-ichi Kira1,6,7 (1.Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Japan, 2.Division of Respirology, Neurology and Rheumatology, Department of Medicine, Kurume University School of Medicine, Japan, 3.School of Physical Therapy, Faculty of Rehabilitation, Reiwa Health Science University, Fukuoka, Japan, 4.Sumitomo Pharma Co., Ltd., Osaka, Japan, 5.School of Medicine Medical Course, Neurology and Stroke Medicine Graduate School of Medicine Degree Program, Yokohama City University, Japan, 6.Translational Neuroscience Center, Graduate School of Medicine, and School of Pharmacy at Fukuoka, International University of Health and Welfare, Japan, 7.Department of Neurology, Brain and Nerve Center, Fukuoka Central Hospital, Japan)
Nobuyuki Eura1,2, Satoru Noguchi1, Masashi Ogasawara1, Aritoshi Iida3, Shinichiro Hayashi1, Ichizo Nishino1 (1.Department of Neuromuscular Research, National Center of Neurology and Psychiatry, Japan, 2.Department of Neurology, Nara Medical University, Japan, 3.Medical Genome Center, National Center of Neurology and Psychiatry, Japan)
Sato Yoshidomi1, Takayuki Fujii1, Hiroyuki Honda2, Kaoru Kashu1, Yukino Miyachi1, Hidenori Ogata1, Ryo Yamasaki1, Toru Iwaki2, Noriko Isobe1 (1.Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Japan, 2.Department of Neuropathology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Japan)
Kimitoshi Kimura1,2, Ayshwarya Subramanian1,2, Zhuoran Yin1,2, Oleg Butovsky1,2, Vijay Kuchroo1,2 (1.Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, USA, 2.Evergrande Center for Immunologic Diseases, Brigham and Women's Hospital and Harvard Medical School, USA)